Latest Medtech News
From AI-powered infection detection and cardiac mapping to robotic navigation and regenerative implants, this week’s MedTech funding activity reflects a broader move toward more intelligent, data-driven and minimally invasive solutions. Details follow below.
As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like these. Subscribe to our Industry Insights for weekly coverage.
CoreMap raises $37M Series C led by Medtronic to advance AFib mapping technology
CoreMap has raised $37M in a Series C round led by Medtronic to accelerate development of its high-density mapping and data analytics platform for atrial fibrillation ablation. The technology is designed to provide physicians with more precise, data-driven guidance for personalized AFib treatment.
CEO Sarah Kalil: “Our goal is simple: to provide electrophysiologists a clearer understanding of AF so they can deliver more targeted, personalized treatment."
Xeltis raises €20.5M to advance aXess toward FDA approval and US launch
Xeltis has raised an additional €20.5M from Horizon 3 Healthcare, the European Innovation Council, Invest-NL and existing investors to advance its aXess™ vascular access implant toward FDA approval and U.S. launch. The funding will support clinical trials, European commercialization, manufacturing scale-up and development of its regenerative implant pipeline.
CEO Eliane Schutte: “This fundraising enables us to advance our aXess pivotal trial in the US, prepare for US market launch and continue our other exciting clinical programs, XABG and XPAD."
Magnendo raises $18M Series A to advance magnetic robotic navigation for stroke care
Magnendo has raised $18M in a Series A round led by Penumbra to support development of its magnetic robotic navigation platform for neuro-endovascular procedures. The funding will accelerate product development and preparation for first-in-human studies of its system combining steerable guidewires, robotics, imaging and AI-driven navigation.
Founder and CEO Yoonho Kim: "This financing enables us to accelerate the productization of our preclinically validated platform and prepare for first-in-human studies."
Vivid Dx raises $15M to advance rapid blood-based infection diagnostics
Vivid Dx has raised $15M in seed funding co-led by Oxford Science Enterprises and Cedars-Sinai Intellectual Property Co. to advance its blood-based diagnostic platform. The technology combines Raman spectroscopy, AI and advanced sample processing to identify pathogens and antibiotic susceptibility directly from blood, aiming to reduce infection diagnosis timelines from days to hours.
CEO Keith O’Neill: “Our goal is to move those answers closer to the moment a blood sample is taken."
SoundHealth raises $12.25M Series A to expand AI-enabled breathing and sleep therapies
SoundHealth has raised $12.25M in a Series A round led by Shangbay Capital to scale its FDA-cleared, AI-enabled non-invasive devices for breathing and sleep disorders. The funding will support expansion of its personalized therapeutics, including the Sonu band and Spatial Sleep platform, which combine proprietary AI with acoustic technology.
CEO Dr. Paramesh Gopi: “We are excited to work with Shangbay Capital to help accelerate the growth of our business,”
Dopl raises $6.3M seed round to advance remote robotic ultrasound platform
Dopl Technologies has raised $6.3M in a seed round led by SpringTide Ventures to accelerate development of its remote robotic ultrasound platform. The funding will support regulatory activities, clinical validation and FDA 510(k) submission for its telerobotic imaging system designed to expand access to ultrasound care.
Co-Founder and CEO Ryan James: “Our outstanding team is energized and now capitalized to move quickly through the regulatory process to deliver reliable, remote robotic ultrasound to patients"
Navi raises A$6.8M to commercialize pediatric vascular access technology in the US
Navi Medical Technologies has raised A$6.8M led by KP Rx, with participation from Innovation Victoria and Pacific Channel, to support U.S. commercialization of its FDA-cleared Neonav® platform. The technology uses real-time ECG guidance to improve placement and monitoring of vascular access devices in neonatal and paediatric patients.
CEO Alex Newton: “For decades, neonatal and paediatric clinicians have relied on technologies that were never designed for their smallest patients. The Neonav® was built to change that.”
Aurenar raises $5.7M seed round to advance neuromodulation technology
Aurenar has raised $5.7M in a seed round co-led by Go Red for Women Venture Fund and Solas BioVentures to advance its V-Link™ neuromodulation system. The funding will support final device development, regulatory submissions and pivotal trials for its FDA Breakthrough Device-designated technology targeting cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Founder and CEO Dr. Eric Leuthardt: "Every dollar of this round is committed to milestones that help us improve outcomes for patients in the most critical moments of their care.”
EVERSION raises €2.3M to expand personalized corrective insole technology
EVERSION Technologies has raised €2.3M in a Seed II round led by Kammerer Holding and Kreissparkasse Biberach to scale its AI-enabled corrective insole platform. The technology combines sensor-based gait analysis, 3D biomechanical modeling and personalized orthotics to address musculoskeletal pain, with the product already covered by German insurers.
Co-Founder and CEO Julia Zimmermann: “I know from my own experience how hip pain can take over daily life. It means so much to me that we can help so many people with our solution,”
Cenglang Biotechnology secures tens of millions of yuan to advance IVD diagnostic technology
Cenglang Biotechnology has raised tens of millions of yuan from Beiyang Haitang Fund to accelerate development of its flow cytometry-based IVD instruments, reagents and biomedical research equipment. The funding will support the company’s efforts to automate and enhance diagnostic workflows through intelligent flow cytometry solutions.
